Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast
2008
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
2015
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin
2001 Standout
Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons
2013 StandoutNobel
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
Identification of the LIM Protein FHL2 as a Coactivator of β-Catenin
2003
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Hepatocellular carcinoma
2003 Standout
Caught up in a Wnt storm: Wnt signaling in cancer
2003
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Medulloblastomics: the end of the beginning
2012
Chromatin Modifications and Their Function
2007 Standout
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts
2010 StandoutNature
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
The casein kinase 1 family: participation in multiple cellular processes in eukaryotes
2005
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Activation of β-catenin in epithelial and mesenchymal hepatoblastomas
2000
Wnt signaling in cancer
2016 Standout
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
2002 Standout
Molecular Mechanism of Liver Development and Regeneration
2007
Wnt proteins are lipid-modified and can act as stem cell growth factors
2003 StandoutNature
The Hedgehog and Wnt signalling pathways in cancer
2001 StandoutNature
Genetics of hepatocellular carcinoma
2000
Osteoporosis: now and the future
2011 Standout
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
2002
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
2016 Standout
The Casein Kinase I Family in Wnt Signaling
2001
The complex language of chromatin regulation during transcription
2007 StandoutNature
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Crystal structure of a β-catenin/Axin complex suggests a mechanism for the β-catenin destruction complex
2003
Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
2010 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
Mutations in the AXIN1 Gene in Advanced Prostate Cancer
2008
Wnt/β-Catenin Signaling and Disease
2012 Standout
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase
2005 StandoutNobel
An efficient and sensitive method for preparing cDNA libraries from scarce biological samples
2014 StandoutNobel
Cancer stem cells and brain tumors: uprooting the bad seeds
2007
Somatic mutations of β-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma
2000
Malignant Gliomas in Adults
2008 Standout
Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer
2015
Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases
2006
Inhibiting Proteasomes in Human HepG2 and LNCaP Cells Increases Endogenous Androgen Receptor Levels
2000
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Wnt/β-Catenin Signaling in Development and Disease
2006 Standout
Neuroblastoma
2007 Standout
NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach
2003
MicroRNAs in Human Cancer
2012
Wnt–β-catenin signalling in liver development, health and disease
2018
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
2011
β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection
1999
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
2006 Standout
MHC antigens and tumor escape from immune surveillance
2001
The Retinoblastoma Binding Protein RBP2 Is an H3K4 Demethylase
2007 StandoutNobel
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
1999
Wnt signalling in stem cells and cancer
2005 StandoutNature
Wnt signaling drives WRM-1/β-catenin asymmetries in early C. elegans embryos
2005 StandoutNobel
Identification of stem cells in small intestine and colon by marker gene Lgr5
2007 StandoutNature
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Primitive Neuroectodermal Tumors of the Central Nervous System
1997
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Histone lysine methylation and demethylation pathways in cancer
2010
β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds
2002 Standout
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of β-catenin
2004
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer.
1999
Chromatin and oxygen sensing in the context of JmjC histone demethylases
2014
Wnt signaling and cancer
2000 Standout
Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors
2002
A molecular fingerprint for medulloblastoma.
2003
Judging a Protein by More Than Its Name: GSK-3
2001
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
The Origins of Medulloblastoma Subtypes
2008
Liver Regeneration
1997 StandoutScience
γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin
2000
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Medulloblastoma Stem Cells
2008
Zur Regenerationskapazität des Leberepithels junger, wiederholt teilhepatektomierter Ratten. Autoradiographische Untersuchungen nach kontinuierlicher Dauerinfusion von3H-Thymidin
1973
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
1999
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Cancerous stem cells can arise from pediatric brain tumors
2003 Standout
β-Catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation
2003
Works of Anne Koch being referenced
Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components
2006
No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours
2004
Molecular analysis of the lissencephaly gene 1 (LIS‐1) in medulloblastomas
1996
Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.
1999
PARENCHYMAL AND LITTORAL CELL PROLIFERATION DURING LIVER REGENERATION.
1964
Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
2001
Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
1989